The Psychedelic News Feed: January 26 – Febraury 1, 2026 Post published:February 2, 2026 Post category:Psychedelic News Feed Archive
Q3 2025: Oregon Psilocybin Services Update Post published:February 2, 2026 Post category:Analysis/News/Pα+
“Changes Are Never Linear”: Joost Breeksema on the Human Side of Psychedelic Therapy Post published:January 27, 2026 Post category:Interviews
The Psychedelic News Feed: January 19 – 25, 2025 Post published:January 27, 2026 Post category:Psychedelic News Feed Archive
Op-Ed: From Psychedelic Prohibition to Psychedelic Public Health Post published:January 26, 2026 Post category:2025 Year in Review/Opinions
Pα+ Psychedelic Bulletin #218: FDA’s Farchione Says Psychedelic INDs Are “a Third” of Her Workload; Ipsos/Psychedelic Alpha Poll; Reunion Eyes Single Phase 3 in PPD; America’s 10 Million Microdosers Post published:January 22, 2026 Post category:Psychedelic Bulletin/Pα+
Psychedelic Funding, Public Markets, and M&A in 2025 Post published:January 20, 2026 Post category:2025 Year in Review/Analysis/Pα+
Op-Ed: Beyond Clinical Trials: Psychedelic-Assisted Therapy in Europe’s Real World Post published:January 19, 2026 Post category:2025 Year in Review/Opinions
The Psychedelic News Feed: January 12 – 18, 2026 Post published:January 19, 2026 Post category:Psychedelic News Feed Archive